|
Session 160
Poster Abstracts
Hypersensitivity Reactions: Other Drug Toxicities
Wednesday, 1-4 pm
Room: Hall B |
981
 |
HCP5-Single Nucleotide Polymorphism: A Simple Screening Tool for Predicting Abacavir Hypersensitivity Reactions
S Colombo1, Andri Rauch*2, M Rotger1, J Fellay3, C Fux2, C Thurnheer2, H Furrer2, D Goldstein3, A Telenti1, and Swiss HIV Cohort Study
1Univ Hosp Lausanne, Switzerland; 2Univ Hosp Bern, Switzerland; and 3Duke Univ, Durham, NC, US |
982
|
Genetic Factors Predicting Abacavir Hypersensitivity and Tolerance in HLA-B*5701+ Individuals: Combined Analysis from PREDICT-1, SHAPE, and a Multinational Study
D Nolan1, D Thorborn2, M Schaefer3, R Laird1, A Rauch4, J Montaner5, A Hughes3, I James1, S Mallal1, Elizabeth Phillips*6, and PREDICT-1(CNA106030) & SHAPE(ABC107442) Study Teams
1Ctr for Clinical Immunology and Biomed Statistics, Murdoch Univ, Royal Perth Hosp, Australia; 2GlaxoSmithKline, Brentford, UK; 3GlaxoSmithKline, Research Triangle Park, NC, US; 4Inselspital Bern, Switzerland; 5BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada; and 6Ctr for Clinical Pharma and Infectious Diseases, Murdoch Univ, Western Australia |
983
|
Risks Associated with Nevirapine Use in Pregnant and Non-pregnant Women
Erika Aaron*1, M Kempf2, S Criniti1, E Tedaldi3, A Warriner2, R Kumar2, E Gracely1, and L Bachmann2
1Drexel Univ Coll of Med, Philadelphia, PA, US; 2Univ of Alabama at Birmingham, US; and 3Temple Univ Sch of Med, Philadelphia, PA, US |
|
